Global Expansion Potential CSL Behring has a strong global presence, with operations in more than 100 countries. This global footprint presents sales opportunities for expanding products and therapies to new markets and reaching more patients in need of life-saving treatments.

Product Innovation Recent product launches, such as the 10g prefilled syringe for Hizentra, showcase CSL Behring's commitment to innovation. Business development professionals can leverage these new product offerings to attract new customers and drive sales growth.

Strategic Partnerships Collaborations with organizations like ON24 and Rare Disorders, Inc. demonstrate CSL Behring's openness to strategic partnerships. Sales development representatives can explore partnership opportunities to enhance product visibility and access new customer segments.

Sustainable Practices Focus The appointment of a Chief Sustainability Officer reflects CSL Behring's dedication to sustainability. Businesses aligned with sustainable practices can leverage this focus as a selling point to attract environmentally conscious clients and differentiate themselves in the market.

Investment in Manufacturing CSL Behring's significant investment in assets, such as the $800 million influenza vaccine plant in Australia, signals growth and expansion. Sales professionals can capitalize on this investment to promote the reliability and scalability of CSL Behring's products to potential buyers.